- Exchange: NASDAQ GS
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Biotech
AVEO Pharmaceuticals Inc+ Add to Watchlist
AVEO:US1.1199 USD 0.0301 2.62%
As of 10:20:50 ET on 03/04/2015.
Company Profile for AVEO Pharmaceuticals Inc (AVEO)
Aveo Pharmaceuticals Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing cancer therapeutics. The Company's lead product candidate is an oral inhibitor of the vascular endothelial growth factor, or VEGF,receptors.
AVEO Pharmaceuticals Inc
Key Executives for AVEO Pharmaceuticals Inc (AVEO)
|Jeno GyurisChief Executive Officer||Michael P BaileyPresident & CEO:Aveo Oncology|
|Joseph VittiglioSenior VP/General Counsel|